Company / Debt per Share
ResMed Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$4.48
FY2025
5-year range
$4.44 / $9.78
FY2021-FY2025
Trend
-5.5%
vs FY2024
Sector context
#74 of 100
Health Care
What the data says
At $4.48, ResMed's debt per share ranks #27 of 100 in the Health Care sector. Debt per Share has fluctuated over the past 10 years, ranging from $1.90 in FY2018 to $9.78 in FY2023.
Based on SEC 10-K filings.
4.48 in FY2025 with a 5-year CAGR of -11.2%.
Improved from $9.78 to $4.48 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -5.2%
- 5-Year CAGR
- -11.2%
- 10-Year CAGR
- -
Sector benchmark
#27 of 100 in Health CareTop 26% of 100This company $4.48 Sector average $45.71
▼
-90.2% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 5.5% year-over-year.
- Ranks #74 out of 100 companies in the Health Care sector.
- Peak debt per share was recorded in FY2023.
- Lowest debt per share in the period was in FY2018.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.48 | -5.5% |
| FY2024 | $4.74 | -51.5% |
| FY2023 | $9.78 | +86.0% |
| FY2022 | $5.25 | +18.3% |
| FY2021 | $4.44 | -45.2% |
| FY2020 | $8.10 | -8.2% |
| FY2019 | $8.82 | +364.6% |
| FY2018 | $1.90 | -75.2% |
| FY2017 | $7.67 | +23.3% |
| FY2016 | $6.22 | +190.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026